in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
215<br />
CDK5/p35 124<br />
CDK6 (cycD3) 125<br />
CDK7/MAT1 (cycH) 125<br />
CDK8 (cycC) 125<br />
CDK9 (cycT1) 125<br />
Cell adhesion 190<br />
cell-based assay development (tool-box) 5<br />
Cell migration 192<br />
Cell proliferation 192<br />
cellular assays 185,204,209<br />
cellular functional GPCR assays 43<br />
cellular k<strong>in</strong>ase assays 107<br />
Cell viability 193<br />
cell viability 193<br />
CENP-E 157<br />
cerep services 4<br />
CGRP 26<br />
CGRP - agonist radioligand 26<br />
Chemok<strong>in</strong>es 28<br />
Chemok<strong>in</strong>e secretion 188<br />
CHK1 131<br />
CHK2 131<br />
Cholecystok<strong>in</strong><strong>in</strong> 30<br />
Chol<strong>in</strong>e 103<br />
chol<strong>in</strong>e transporter (CHT1)- antagonist<br />
radioligand 103<br />
CK1a 144<br />
CK1e 144<br />
CK2 (case<strong>in</strong> k<strong>in</strong>ase 2) 125<br />
CK1 (prote<strong>in</strong>-ser<strong>in</strong>e/threon<strong>in</strong>e k<strong>in</strong>ases) 144<br />
Class A Orphans 62<br />
Cl - channel (GABA-gated)- antagonist<br />
radioligand 86,98<br />
CLK1 125<br />
CLK2 126<br />
CMGC (prote<strong>in</strong>-ser<strong>in</strong>e/threon<strong>in</strong>e k<strong>in</strong>ases) 124<br />
Complement 5a 31<br />
Compound:<br />
- form & format 210<br />
- frozen samples 211<br />
- requested <strong>in</strong>formation 208<br />
- management process 209<br />
- shipment 210<br />
- submission form 208,210<br />
Compound management 4<br />
COMT (catechol-O-methyl transferase) 179<br />
confidentiality (Master service agreement) 208<br />
constitutive NOS (cerebellar) 177<br />
constitutive NOS (endothelial) 177<br />
Contacts (<strong>Cerep</strong> contacts) back cover<br />
conventional patch-clamp 94,96,98<br />
Corticotrop<strong>in</strong> releas<strong>in</strong>g factor 31<br />
COT k<strong>in</strong>ase (MAP3K8) 145<br />
COX 1 178<br />
COX 2 178<br />
CRF 1 31<br />
CRF 1 - agonist radioligand 31<br />
CRF 2a 32<br />
CRF 2a - agonist radioligand 32<br />
CRIK 137<br />
CSK 119<br />
CT (calciton<strong>in</strong>) 25<br />
CT (calciton<strong>in</strong>)- agonist radioligand 25<br />
CTK 119<br />
CTK (prote<strong>in</strong>-tyros<strong>in</strong>e k<strong>in</strong>ases) 118<br />
customer support 208,211<br />
custom offer 185<br />
CXCR2 (IL-8B) 29<br />
CXCR2 (IL-8B)- agonist radioligand 29<br />
CXCR4 30<br />
CXCR4 - agonist radioligand 29<br />
Cyclases 181<br />
CysLT 1 (LTD 4 ) 44<br />
CysLT 1 (LTD 4 )- agonist radioligand 44<br />
CysLT 2 (LTC 4 ) 45<br />
CysLT 2 (LTC 4 )- agonist radioligand 44<br />
Cyste<strong>in</strong>e proteases 168<br />
Cytok<strong>in</strong>es 83<br />
Cytok<strong>in</strong>e secretion 188<br />
[D]<br />
D 1 32<br />
D 1 - antagonist radioligand 32<br />
D 2 33<br />
D 2L - antagonist radioligand 33<br />
D 2S 33<br />
D 2S - agonist radioligand 33<br />
D 2S - antagonist radioligand 33<br />
D 3 34<br />
D 3 - agonist radioligand 34<br />
D 3 - antagonist radioligand 33<br />
D 4.4 34<br />
D 4.4 - antagonist radioligand 34<br />
D 5 35<br />
D 5 - agonist radioligand 34<br />
D 5 - antagonist radioligand 34<br />
DAPK1 132<br />
DAPK2 132<br />
data and reports 9<br />
Data Onl<strong>in</strong>e 9<br />
Data Onl<strong>in</strong>e account 211<br />
data turnaround 205<br />
DCAMKL1 132<br />
DCAMKL2 132<br />
DDR2 k<strong>in</strong>ase 109<br />
deliverables 205<br />
delta 2 (DOP) 59<br />
delta 2 (DOP)- agonist radioligand 59<br />
dipeptidyl peptidase IV (DPP-IV) 167<br />
DLK1 (MAP3K12) 149<br />
DNA polymerase b 158<br />
DNA polymerase I 157<br />
DNA repair & mitotic enzymes 157<br />
Dopam<strong>in</strong>e 32,104<br />
dopam<strong>in</strong>e release (activator effect) 185<br />
dopam<strong>in</strong>e transporter - antago. radioligand 104<br />
dopam<strong>in</strong>e uptake 104<br />
DP 1 63<br />
DP 1 - agonist radioligand 63<br />
DRAK1 132<br />
drug development 199<br />
drug discovery 4<br />
drug-drug <strong>in</strong>teraction 199,200<br />
drug profile <strong>in</strong>terpretation 7<br />
DYRK1a 126<br />
DYRK2 126<br />
DYRK3 126<br />
DYRK4 126<br />
[E]<br />
ECE-1 171,172<br />
Eg5 158<br />
EGF - agonist radioligand 87<br />
EGFR k<strong>in</strong>ase 109<br />
EGFR k<strong>in</strong>ase (A431 cells) - AlphaScreen 109<br />
EGFR k<strong>in</strong>ase (A431 cells) - impedance 109<br />
EGFR k<strong>in</strong>ase (Hela cells) 109<br />
EGFR k<strong>in</strong>ase (MDA-MB-231 cells) 109<br />
EGF-stimulated A-431 proliferation 192<br />
elastase 168<br />
Endothel<strong>in</strong> 35<br />
enzyme assays (test<strong>in</strong>g conditions) 204,209<br />
EP 1 64<br />
EP 1 - agonist radioligand 64<br />
EP 2 64<br />
EP 2 - agonist radioligand 64<br />
EP 3 64<br />
EP 3 - agonist radioligand 64<br />
EP 4 65<br />
EP 4 - agonist radioligand 65<br />
EphA1 k<strong>in</strong>ase 110<br />
EphA2 k<strong>in</strong>ase 110<br />
EphA3 k<strong>in</strong>ase 110<br />
EphA4 k<strong>in</strong>ase 110<br />
EphA5 k<strong>in</strong>ase 110<br />
assay list & <strong>in</strong>dex ❚<br />
EphA6 k<strong>in</strong>ase 110<br />
EphA7 k<strong>in</strong>ase 111<br />
EphA8 k<strong>in</strong>ase 111<br />
EphB1 k<strong>in</strong>ase 111<br />
EphB2 k<strong>in</strong>ase 111<br />
EphB3 k<strong>in</strong>ase 111<br />
EphB4 k<strong>in</strong>ase 111<br />
Epigenetic & DNA-related enzymes 157<br />
ERa - agonist fluoligand 79<br />
ERb - agonist fluoligand 79<br />
ERK 1 127<br />
ERK 1/2 127<br />
ERK 2 (P42 mapk ) 127<br />
ERK 5 (MAPK7) 127<br />
ER (non-selective)- agonist radioligand 79<br />
ET A 35<br />
ET A - agonist radioligand 35<br />
ET B 36<br />
ET B - agonist radioligand 35<br />
ExpresScreen option 211<br />
Expression of endothelial adhesion prote<strong>in</strong>s:<br />
- ELAM-1 191<br />
- ICAM1/VCAM-1 190<br />
- VCAM-1 191<br />
[F]<br />
FAAH (fatty acid amide hydrolase) 183<br />
FAK 119<br />
Fer k<strong>in</strong>ase 119<br />
Fes k<strong>in</strong>ase 120<br />
FFA1(GPR40) 37<br />
FFA2 (GPR43) 37<br />
FFA3 (GPR41) 37<br />
FGFR k<strong>in</strong>ase 112<br />
FGFR1 k<strong>in</strong>ase 112<br />
FGFR2 k<strong>in</strong>ase 112<br />
FGFR3 k<strong>in</strong>ase 112<br />
FGFR4 k<strong>in</strong>ase 112<br />
Fgr k<strong>in</strong>ase 120<br />
FLT-1 k<strong>in</strong>ase (VEGFR1) 112<br />
FLT-3 k<strong>in</strong>ase 113<br />
FLT-3 D835Y k<strong>in</strong>ase 113<br />
FLT-4 k<strong>in</strong>ase (VEGFR3) 113<br />
fMLP 36<br />
fMLP - agonist radioligand 36<br />
Fms/CSFR k<strong>in</strong>ase 113<br />
form & format (compound) 211<br />
formula weight (FW) 208<br />
n-formyl peptide 36<br />
FP 65<br />
FP - agonist radioligand 65<br />
Free fatty acid 37<br />
Free radical secretion 190<br />
FRK 120<br />
frozen samples (compound) 211<br />
functional nuclear receptor assays 80<br />
Fyn k<strong>in</strong>ase 120<br />
[G]<br />
GABA 38,84,97,104<br />
GABA A 85,98<br />
GABA A1 (a1,b2,g2)- agonist radioligand 85,97<br />
GABA A (automated patch-clamp) 85,97<br />
GABA A (automated patch-clamp,functional<br />
screen<strong>in</strong>g) 85,97<br />
GABA A (conventional patch-clamp) 85,98<br />
GABA B 38<br />
GABA B ( 1b )- antagonist radioligand 38<br />
GABA (non-selective)- agonist radioligand 84<br />
GABA transam<strong>in</strong>ase 179<br />
GABA transporter - antagonist radioligand 104<br />
GAL 1 - agonist radioligand 38<br />
GAL 2 39<br />
GAL 2 - agonist radioligand 39<br />
Galan<strong>in</strong> 38<br />
<strong>Cerep</strong><br />
services<br />
Receptors<br />
Ion<br />
channels<br />
Transporters<br />
K<strong>in</strong>ases<br />
Epigenetic &<br />
DNA-related<br />
enzymes<br />
Other<br />
enzymes<br />
Specialized<br />
cellular<br />
assays<br />
Standard<br />
profiles<br />
Test<strong>in</strong>g<br />
conditions<br />
Order<strong>in</strong>g<br />
<strong>in</strong>formation<br />
<br />
Assay list<br />
& <strong>in</strong>dex
Change language